Australia Patent: Regeneron Pharmaceuticals Files Application for 'Methods for treating or preventing SARS-CoV-2 infections and COVID-19 with anti-SARS-CoV-2 spike glycoprotein antibodies'

  • Meagan P. O'Brien

Press/Media

Period3 Feb 2023

Media coverage

1

Media coverage

  • TitleAustralia Patent: Regeneron Pharmaceuticals Files Application for 'Methods for treating or preventing SARS-CoV-2 infections and COVID-19 with anti-SARS-CoV-2 spike glycoprotein antibodies'
    Media name/outletAustralian Government News (Ht Media)
    Country/TerritoryAustralia
    Date3/02/23
    PersonsMeagan P. O'Brien